UdaanPath · Daily Edition

समाचार | Current Affairs

शुक्रवार, 18 जुलाई 2026

1 हिंदी · 1 English

आज का अंक

SSC · Railway · Banking · UPSC · State PSC

सभी2 विज्ञान2

विज्ञानहिं

CDSCO ने Wegovy (Semaglutide 2.4 mg) को India में Approve किया — Obesity और Metabolic Dysfunction के इलाज के लिए; Novo Nordisk

India के drug regulator CDSCO (Central Drugs Standard Control Organisation) ने 17 जुलाई 2026 को Novo Nordisk के Wegovy (…

पढ़ें →

Science & Tech

CDSCO Approves Wegovy (Semaglutide 2.4 mg) in India for Obesity Treatment — Novo Nordisk; First GLP-1 for Weight Loss in India

India's Central Drugs Standard Control Organisation (CDSCO) approved Novo Nordisk's Wegovy (semaglutide injection 2.4 mg…

← 17 July 2026 ↑ All editions

Official WhatsApp Channel

Get Instant Alerts on WhatsApp

Subscribe once and get notified the moment something relevant to your career is published. No spam, no noise.

Government Job Openings
College Admissions
Entrance Exam Dates
Admit Card Releases
Results & Cut-offs
New Courses Added

Join Channel — Free10,000+ members

Scan to join UdaanPath WhatsApp Channel

Scan to Join

Point your camera at the QR